ArticleCancers2023

Antiandrogen-Equipped Histone Deacetylase Inhibitors Selectively Inhibit Androgen Receptor (AR) and AR-Splice Variant (AR-SV) in Castration-Resistant Prostate Cancer (CRPC).

Balaji Chandrasekaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.